article thumbnail

Arcturus Therapeutics Gets $3M From Cystic Fibrosis Foundation

socalTECH

San Diego-based Arcturus Therapeutics , a developer of mRNA-based treatments for disease, has signed a deal to receive up to $3M in funding from the Cystic Fibrosis Foundation Therapeutics, a nonprofit which supports drug discovery and development. READ MORE>>.

Arcturus 167
article thumbnail

Arcturus Get Exit At Pliant

socalTECH

Pasadena-based venture capital firm Arcturus Capital has scored an exit out of its portfolio this morning, as Milpitas, California-based Pliant Technology was acquired by SanDisk in a deal worth $327M. Arcturus first invested in Pliant in 2007. SanDisk is a major manufacturer of flash memory.

Arcturus 150
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AeroVironment Completes $405M Arcturus UAV Acquisition

socalTECH

Simi Valley-based Aerovironment said yesterday that it has completed the $405M acquisition of Arcturus UAV, a designer and manufacturer of high performance, unmanned aircraft systems (UAS). The deal had originally been announced on January 13th.

Arcturus 124
article thumbnail

AeroVironment Acquires Arcturus UAV For $405M

socalTECH

Simi Valley-based unmanned aerial vehicle maker Aerovironment says it is acquiring Arcturus UAV, a developer of unmanned aircraft used by the military, in a deal worth $405M in cash and stock. AeroVironment said it would pay $355M in cash and $50M in stock for Arcturus, which is based in Petaluma, Claifornia.

Arcturus 113
article thumbnail

Arcturus Studios’ Software Powers Holographic Videos

L.A. Business Journal

Augmented reality and holographic technology exist largely as a novelty for most Americans. But as smartphone cameras evolve and 5G networks come online, many investors and businesses are betting that the technology will become commonplace.

Arcturus 223
article thumbnail

Arcturus Poised to Move Liver Drug, COVID-19 Vaccine Into Clinic

Xconomy

Messenger RNA drug developer Arcturus Therapeutics is ready to kick off its first-ever human trials this year, beginning clinical evaluation of its lead drug candidate and testing a vaccine designed to target the novel coronavirus. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Arcturus 117
article thumbnail

Arcturus Therapeutics In Deal With Johnson & Johnson Innovation

socalTECH

San Diego-based RNA therapeutics developer Arcturus Therapeutics announced this morning that it is in a strategic collaboration deal, with Johnson & Johnson Innovation. Plus, Janssen will assume responsibility for development and commercialization costs associated with the new program.

Arcturus 100